Literature DB >> 2766463

Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver.

T Nakajima1, E Elovaara, S S Park, H V Gelboin, E Hietanen, H Vainio.   

Abstract

The contribution of cytochrome P-450 isozymes to benzene metabolism in liver microsomes from fed, fasted, pyrazole-, phenobarbital (PB)- and ethanol-treated rats and in respective isocaloric controls was investigated using monoclonal antibodies (mAbs). Clone 1-7-1 mAb did not inhibit benzene metabolism, whereas clone 2-66-3 inhibited only in PB-induced microsomes at a high concentration of benzene (6.26 mM), and clone 1-91-3 mAb inhibited benzene metabolism in all cases. The degree of inhibition was as follows: fed congruent to isocaloric control congruent to PB less than fasted less than pyrazole congruent to ethanol. The pattern of inhibition was similar with clone 1-91-3 for low (0.23 mM) and high concentrations of benzene, except in PB-induced microsomes. Western blot analysis showed that clone 1-7-1 mAb did not bind any liver microsomal protein in the region of cytochrome P-450s, whereas with clone 2-66-3 a clear-cut band was seen only in liver microsomes from PB-treated rats, with clone 1-98-1, a band was detected in microsomes from all treated groups, in the following order: PB = isocaloric control less than fed less than fasted less than pyrazole less than ethanol. These results indicate that (i) cytochromes P-450b,e and P-450j contribute to benzene metabolism in rat liver; (ii) the former has a low affinity to benzene and is induced by PB; and (iii) P-450j has a high affinity to benzene and is induced by 1-day fasting, pyrazole and ethanol, but decreased by PB treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766463     DOI: 10.1093/carcin/10.9.1713

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Pulmonary toxicity of inhaled styrene in acetone-, phenobarbital- and 3-methylcholanthrene-treated rats.

Authors:  E Elovaara; H Vainio; A Aitio
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Enzyme induction by ethanol consumption affects the pharmacokinetics of inhaled m-xylene only at high levels of exposure.

Authors:  T Kaneko; P Y Wang; A Sato
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

3.  Kinetic studies on toluene metabolism in ethanol- and phenobarbital-induced rat liver microsomes in vitro.

Authors:  R S Wang; T Nakajima
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Immunochemical detection of cytochrome P450 isozymes induced in rat liver by n-hexane, 2-hexanone and acetonyl acetone.

Authors:  T Nakajima; E Elovaara; S S Park; H V Gelboin; H Vainio
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Ethanol and food deprivation induced enhancement of hepatotoxicity in rats given carbon tetrachloride at low concentration.

Authors:  H Ikatsu; T Okino; T Nakajima
Journal:  Br J Ind Med       Date:  1991-09

6.  Enzymes induced by ethanol differently affect the pharmacokinetics of trichloroethylene and 1,1,1-trichloroethane.

Authors:  T Kaneko; P Y Wang; A Sato
Journal:  Occup Environ Med       Date:  1994-02       Impact factor: 4.402

7.  Exposure to various benzene derivatives differently induces cytochromes P450 2B1 and P450 2E1 in rat liver.

Authors:  I Gut; Y Terelius; E Frantík; I Linhart; P Soucek; B Filipcová; H Klucková
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  Expression of cytochrome P4502E1 gene in hepatocellular carcinoma.

Authors:  Xiao-Bo Man; Liang Tang; Xiu-Hua Qiu; Li-Qun Yang; Hui-Fang Cao; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

9.  Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity.

Authors:  I Gut; V Nedelcheva; P Soucek; P Stopka; B Tichavská
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.